Zynerba Pharmaceuticals (NASDAQ:ZYNE)

Zynerba Pharmaceuticals (NASDAQ:ZYNE)


Share Price
$ 5.22
Change
-0.11 (-2.06 %)
Market Cap
$92.01 m
Proactive Investors - Run By Investors For Investors

Zynerba Pharmaceuticals

Zynerba’s mission is to develop next-generation transdermally-delivered cannabinoid therapeutics to help address significant unmet medical needs and improve the lives of patients with rare and near-rare neuropsychiatric conditions such as Fragile X syndrome (FXS), Autism Spectrum Disorder (ASD), 22q, and a heterogeneous group of rare and ultra-rare epilepsies known as developmental and...

EPIC: ZYNE
Market: NASDAQ:ZYNE
52-week High/Low: $12.50 / $2.82
Sector: Pharma & Biotech
Market Cap: $92.01M
Website: zynerba.com
col 3
col 4
col 5
col 6
Video RSS

Videos

VIEW ALL VIDEOS
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use